glp 1 alcohol addiction GLP-1 medications: The next big thing in use disorder treatment? – Recovery Research Institute GLP-1s Could Help Reduce Alcohol

Back Patchen, T (8 March 2024) 'FDA approves novo's obesity drug Wegovy to reduce cardiovascular events', Biospace

Abstract Recent literature shows that GLP-1 receptor agonists are highly effective for weight loss and improving metabolic and cardiovascular health, often surpassing the results of lifestyle interventions alone, such as exercise and diet modification

diabetes obesity Ozempic semaglutide type 2 diabetes newsGP weekly poll As a GP, would you work more hours in the after-hours period if there was more funding for this work, such as higher rebates or other incentives?

They can work together quite nicely

Cmo acta la L-Arginina